Bayesian design of biosimilars clinical programs involving multiple therapeutic indications (Q5128840)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Bayesian design of biosimilars clinical programs involving multiple therapeutic indications |
scientific article; zbMATH DE number 7265720
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bayesian design of biosimilars clinical programs involving multiple therapeutic indications |
scientific article; zbMATH DE number 7265720 |
Statements
Bayesian design of biosimilars clinical programs involving multiple therapeutic indications (English)
0 references
26 October 2020
0 references
Bayesian clinical trial design
0 references
Bayesian type I error rate
0 references
biosimilars
0 references
equivalence trial
0 references
